Compare TCRX & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TCRX | IH |
|---|---|---|
| Founded | 2018 | 1996 |
| Country | United States | China |
| Employees | N/A | 558 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.1M | 85.6M |
| IPO Year | 2021 | 2020 |
| Metric | TCRX | IH |
|---|---|---|
| Price | $1.11 | $1.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 937.1K | 7.4K |
| Earning Date | 05-08-2026 | 03-31-2026 |
| Dividend Yield | N/A | ★ 5.88% |
| EPS Growth | ★ 12.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,325,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.81 | N/A |
| P/E Ratio | ★ N/A | $7.30 |
| Revenue Growth | ★ 266.65 | N/A |
| 52 Week Low | $0.88 | $1.55 |
| 52 Week High | $2.57 | $3.60 |
| Indicator | TCRX | IH |
|---|---|---|
| Relative Strength Index (RSI) | 44.12 | 43.10 |
| Support Level | $0.93 | $1.55 |
| Resistance Level | $1.21 | $1.83 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 5.27 | 19.55 |
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.